batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. After Dreamm-7, how about more multiple myeloma conjugates? 9 February 2024 Astra's next wave goes beyond subcutaneous Imfinzi 8 February 2024 BioNTech bails out Autolus 8 February 2024 Jazz joins the KRAS band with Redx deal 7 February 2024 Gilead deals more checkpoint disappointment 7 February 2024 The pullback from RET inhibition 6 February 2024 Bristol shows its alnuctamab hand 5 February 2024 Bicycle rides onto its accelerated pathway 31 January 2024 Load More